Karydas Daphne 4
4 · Mineralys Therapeutics, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Karydas Daphne
Director
Transactions
- Award
Stock Option
2025-02-13+32,900→ 32,900 totalExercise: $10.20Exp: 2035-02-13→ Common Stock (32,900 underlying)
Footnotes (1)
- [F1]The stock option vests in 12 substantially equal monthly installments following the date of grant.